Related references
Note: Only part of the references are listed.p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
James G. Jackson et al.
CANCER CELL (2012)
Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway
Zhe Lu et al.
EXPERIMENTAL CELL RESEARCH (2011)
Missense Mutations Located in Structural p53 DNA-Binding Motifs Are Associated With Extremely Poor Survival in Chronic Lymphocytic Leukemia
Martin Trbusek et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
p53 mutant breast cancer patients expressing p53 gamma have as good a prognosis as wild-type p53 breast cancer patients
Jean-Christophe Bourdon et al.
BREAST CANCER RESEARCH (2011)
A novel quantitative PCR of proliferation markers (Ki-67, topoisomerase IIα, and TPX2): an immunohistochemical correlation, testing, and optimizing for mantle cell lymphoma
Helena Brizova et al.
VIRCHOWS ARCHIV (2010)
Mutant p53 mediates survival of breast cancer cells
L. Y. Lim et al.
BRITISH JOURNAL OF CANCER (2009)
Identification of Smyd4 as a Potential Tumor Suppressor Gene Involved in Breast Cancer Development
Liping Hu et al.
CANCER RESEARCH (2009)
Nuclear Receptor Co-repressor Is Required to Maintain Proliferation of Normal Intestinal Epithelial Cells in Culture and Down-modulates the Expression of Pigment Epithelium-derived Factor
Genevieve Doyon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
TP53 mutations and survival in squamous-cell carcinoma of the head and neck
M. Luana Poeta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer
F. Vegran et al.
ONCOGENE (2007)
Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy
Frederique Wegran et al.
CLINICAL CANCER RESEARCH (2006)
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
M Olivier et al.
CLINICAL CANCER RESEARCH (2006)
Transcriptional regulation by p53: one protein, many possibilities
O. Laptenko et al.
CELL DEATH AND DIFFERENTIATION (2006)
The complexity of p53 stabilization and activation
M. F. Lavin et al.
CELL DEATH AND DIFFERENTIATION (2006)
How many mutant p53 molecules are needed to inactivate a tetramer?
WM Chan et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Regulation of human p53 activity and cell localization by alternative splicing
A Ghosh et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Loss of heterozygosity of a locus in the chromosomal region 17p13.3 is associated with increased cell proliferation in astrocytic tumors
C Sarkar et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Biogenesis of p53 involves cotranslational dimerization of monomers and posttranslational dimerization of dimers - Implications on the dominant negative effect
CD Nicholls et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Enhancement of mdr1 gene expression in normal tissue adjacent to advanced breast cancer
M Arnal et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
Share Paper
